BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11020136)

  • 1. Effects of obesity on pharmacokinetics implications for drug therapy.
    Cheymol G
    Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of drugs in obesity. An update.
    Cheymol G
    Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of obesity on the pharmacokinetics of drugs in humans.
    Hanley MJ; Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthesia in the obese patient: pharmacokinetic considerations.
    Casati A; Putzu M
    J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    Cheymol G; Poirier JM; Carrupt PA; Testa B; Weissenburger J; Levron JC; Snoeck E
    Br J Clin Pharmacol; 1997 Jun; 43(6):563-70. PubMed ID: 9205815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug pharmacokinetics in the obese.
    Cheymol G
    Fundam Clin Pharmacol; 1988; 2(3):239-56. PubMed ID: 3042569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine pharmacokinetics in obese and lean subjects.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Ann Pharmacother; 1995 Sep; 29(9):843-7. PubMed ID: 8547729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose adjustment of anaesthetics in the morbidly obese.
    Ingrande J; Lemmens HJ
    Br J Anaesth; 2010 Dec; 105 Suppl 1():i16-23. PubMed ID: 21148651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of quinine in obesity.
    Viriyayudhakorn S; Thitiarchakul S; Nachaisit S; Ho PC; Wanwimolruk S
    Trans R Soc Trop Med Hyg; 2000; 94(4):425-8. PubMed ID: 11127249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
    Cheymol G
    Bull Acad Natl Med; 1990 Oct; 174(7):959-67; discussion 967-8. PubMed ID: 1981983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic changes in obesity].
    Girardin E; Bruguerolle B
    Therapie; 1993; 48(4):397-402. PubMed ID: 8128423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial dosing in obese patients.
    Wurtz R; Itokazu G; Rodvold K
    Clin Infect Dis; 1997 Jul; 25(1):112-8. PubMed ID: 9243045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remifentanil pharmacokinetics in obese versus lean patients.
    Egan TD; Huizinga B; Gupta SK; Jaarsma RL; Sperry RJ; Yee JB; Muir KT
    Anesthesiology; 1998 Sep; 89(3):562-73. PubMed ID: 9743391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers.
    Le Jeunne C; Poirier JM; Cheymol G; Ertzbischoff O; Engel F; Hugues FC
    Eur J Clin Pharmacol; 1991; 41(2):171-4. PubMed ID: 1683835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control.
    Sankaralingam S; Kim RB; Padwal RS
    Can J Cardiol; 2015 Feb; 31(2):167-76. PubMed ID: 25661551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review.
    Macgregor AM; Boggs L
    Obes Surg; 1996 Feb; 6(1):17-27. PubMed ID: 10731246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.